Cargando…

Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder

Detalles Bibliográficos
Autores principales: Maillart, Elisabeth, Renaldo, Florence, Papeix, Caroline, Deiva, Kumaran, Bonheur, Julie, Kwon, Teresa, Boespflug-Tanguy, Odile, Germanaud, David, Marignier, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051209/
https://www.ncbi.nlm.nih.gov/pubmed/32098863
http://dx.doi.org/10.1212/NXI.0000000000000683
_version_ 1783502731058610176
author Maillart, Elisabeth
Renaldo, Florence
Papeix, Caroline
Deiva, Kumaran
Bonheur, Julie
Kwon, Teresa
Boespflug-Tanguy, Odile
Germanaud, David
Marignier, Romain
author_facet Maillart, Elisabeth
Renaldo, Florence
Papeix, Caroline
Deiva, Kumaran
Bonheur, Julie
Kwon, Teresa
Boespflug-Tanguy, Odile
Germanaud, David
Marignier, Romain
author_sort Maillart, Elisabeth
collection PubMed
description
format Online
Article
Text
id pubmed-7051209
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-70512092020-03-13 Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder Maillart, Elisabeth Renaldo, Florence Papeix, Caroline Deiva, Kumaran Bonheur, Julie Kwon, Teresa Boespflug-Tanguy, Odile Germanaud, David Marignier, Romain Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2020-02-25 /pmc/articles/PMC7051209/ /pubmed/32098863 http://dx.doi.org/10.1212/NXI.0000000000000683 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Clinical/Scientific Notes
Maillart, Elisabeth
Renaldo, Florence
Papeix, Caroline
Deiva, Kumaran
Bonheur, Julie
Kwon, Teresa
Boespflug-Tanguy, Odile
Germanaud, David
Marignier, Romain
Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
title Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
title_full Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
title_fullStr Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
title_full_unstemmed Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
title_short Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
title_sort dramatic efficacy of ofatumumab in refractory pediatric-onset aqp4-igg neuromyelitis optica spectrum disorder
topic Clinical/Scientific Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051209/
https://www.ncbi.nlm.nih.gov/pubmed/32098863
http://dx.doi.org/10.1212/NXI.0000000000000683
work_keys_str_mv AT maillartelisabeth dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT renaldoflorence dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT papeixcaroline dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT deivakumaran dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT bonheurjulie dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT kwonteresa dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT boespflugtanguyodile dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT germanauddavid dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder
AT marignierromain dramaticefficacyofofatumumabinrefractorypediatriconsetaqp4iggneuromyelitisopticaspectrumdisorder